Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

SHP limits TLR signaling, an inducible transcriptional corepressor

Cellular & Molecular Immunology volume 8, pages 445–446 (2011)Cite this article

Toll-like receptor (TLR) signaling stimulated by diverse microbial components plays a pivotal role in innate immunity by eliciting a powerful proinflammatory response that is essential for pathogen elimination. However, uncontrolled inflammation can result in tissue damage. Thus, TLR signaling has to be tightly controlled to maintain immune balance in the organism. The paradigm for modulating TLR signaling seems to center on the canonical nuclear factor-κB (NF-κB) pathway, most likely because of the central role of NF-κB in the production of various proinflammatory cytokines.1 In a recent issue of Nature Immunology, Yuk et al. have reported the identification of a novel endogenous NF-κB inhibitor in TLR signaling—small heterodimer partner (SHP)2 Interestingly, SHP functions in a self-regulating system: TLR signaling induces the expression of SHP in macrophages through Ca2+-dependent activation of AMP-activated protein kinase (AMPK), which has anti-inflammatory effects3 SHP in turn decreases the expression of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) by physically binding to two key components of the canonical NF-κB pathway, namely, RelA/p65 and TNF receptor-associated factor 6 (TRAF6) This work demonstrates an essential role for SHP in the negative control of TLR signaling and provides a novel underlying molecular mechanism.

SHP is an atypical orphan member of the nuclear receptor superfamily Lacking a DNA-binding domain, SHP is a transcriptional corepressor that is involved in endocrine regulation.4 By examining the susceptibility of SHP-deficient mice to endotoxin shock, Yuk et al. have made the notable observation that SHP protects mice against the lethality induced by experimental endotoxemia. The decreased survival of SHP-deficient mice in response to endotoxin is attributed to augmented expression of proinflammatory cytokines from bone marrow-derived cells. With bone marrow-derived macrophages (BMDMs) as the major cell model, the authors showed that SHP participates in the regulation of inflammatory responses induced by various TLR agonists. Because several nuclear receptors exert anti-inflammatory effects by suppressing the transcription of genes encoding proinflammatory cytokines,5 it was reasonable for the authors to analyze p65, the major transactivating subunit of NF-κB.6 Indeed, they found that SHP hinders p65 nuclear translocation and DNA binding, which is associated with reduced Tnf promoter activity. Their results from coimmunoprecipitation and confocal analysis suggest an interaction between p65 and SHP in BMDMs. Even though these data help explain the anti-inflammatory effects of SHP, they indicate no novel molecular mechanism. Yuk et al. further showed that SHP interferes with the molecular events upstream of p65. The degradation of NF-κB inhibitor IκBα and the activation of the IκB kinase upon TLR stimulation correlate inversely with the protein level of SHP. By examining the initial steps of TLR signaling, the authors next showed that the lys63 (K63)-linked polyubiquitination of TRAF6 upon TLR stimulation is enhanced with SHP deficiency, but is impaired with SHP overexpression. Their results from coimmunoprecipitation and confocal analysis suggest that cytoplasmic SHP interacts with p65, but not TRAF6, in unstimulated resting BMDMs, and that TLR signaling leads to the binding of SHP to TRAF6, which is associated with reduced SHP–p65 interaction. The authors propose that the binding of SHP to TRAF6 hinders TRAF6 polyubiquitination because the interaction of TRAF6 with SHP depends on an amino-terminal RING domain, while this domain is required for the binding of TRAF6 to an E2 ubiquitin-conjugating enzyme and for TRAF6 to act as an E3 ubiquitin ligase.7 Moreover, the authors provide data indicating that TLR signaling induces endogenous SHP expression in an AMPK-dependent manner, consistent with previous findings that show that AMPK contributes to the induction of shp expression by various extracellular stimuli.8, 9 TLR-dependent activation of AMPK requires intracellular Ca2+ influx, whereas other extracellular stimuli might trigger AMPK activation in a Ca2+-independent manner. AMPK activation mediates SHP expression via transcription factor upstream stimulatory factor-1. Collectively, the complicated and challenging series of experiments performed identify previously unrecognized dual regulatory functions of SHP in TLR signaling and provide new insights into the important post-translational regulatory roles of nuclear receptors.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Liew FY, Xu D, Brint EK, O'Neill LAJ . Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446–458.

    Article  CAS  Google Scholar 

  2. Yuk JM, Shin DM, Lee HM, Kim JJ, Kim SW, Jin HS et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol 2011; 12: 742–751

    Article  CAS  Google Scholar 

  3. Sag D, Carling D, Stout RD, Shuttles J . Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008; 181: 8633–8641.

    Article  CAS  Google Scholar 

  4. Bavner A, Sabyal S, Gustafsson JA, Treuter E . Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 2005; 16: 478–488.

    Article  CAS  Google Scholar 

  5. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 2005; 122: 707–721.

    Article  CAS  Google Scholar 

  6. Wissink S, van Heerde EC, Schmitz ML Kalkhoven E vander Burg B et al. Distinct domains of the RelA NF-κB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 1997; 272: 22278–22284.

    Article  CAS  Google Scholar 

  7. Deng L, Wang C, Spencer E, Yang L, Braun A, You J et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000; 103: 351–361.

    Article  CAS  Google Scholar 

  8. Chanda D, Li T, Song KH, Kim TH, Sim J, Lee CH et al. Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes. J Biol Chem 2009; 284: 28610–28521.

    Article  Google Scholar 

  9. Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008; 57: 306–314.

    Article  CAS  Google Scholar 

  10. Sun SC . Deubiquitylation and regulation of the immune response. Nat Rev Immunol 2008; 8: 501–511.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Immunology, Institute of Basic Medical Sciences, Beijing, China

    Jiyan Zhang & Beifen Shen

Authors
  1. Jiyan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beifen Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, J., Shen, B. SHP limits TLR signaling, an inducible transcriptional corepressor. Cell Mol Immunol 8, 445–446 (2011). https://doi.org/10.1038/cmi.2011.31

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2011.31

This article is cited by

Search

Advanced search

Quick links